AEterna Zentaris (TSX:AEZS) Days Inventory : 132.50 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is AEterna Zentaris Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). AEterna Zentaris's Average Total Inventories for the three months ended in Dec. 2023 was C$0.11 Mil. AEterna Zentaris's Cost of Goods Sold for the three months ended in Dec. 2023 was C$0.07 Mil. Hence, AEterna Zentaris's Days Inventory for the three months ended in Dec. 2023 was 132.50.

The historical rank and industry rank for AEterna Zentaris's Days Inventory or its related term are showing as below:

TSX:AEZS' s Days Inventory Range Over the Past 10 Years
Min: 66.43 Med: 217.7 Max: 644.16
Current: 235.47

During the past 13 years, AEterna Zentaris's highest Days Inventory was 644.16. The lowest was 66.43. And the median was 217.70.

TSX:AEZS's Days Inventory is ranked worse than
57.16% of 649 companies
in the Biotechnology industry
Industry Median: 191.36 vs TSX:AEZS: 235.47

AEterna Zentaris's Days Inventory declined from Dec. 2022 (415.25) to Dec. 2023 (132.50).

Inventory Turnover measures how fast the company turns over its inventory within a year. AEterna Zentaris's Inventory Turnover for the three months ended in Dec. 2023 was 0.69.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. AEterna Zentaris's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.65.

AEterna Zentaris Days Inventory Historical Data

The historical data trend for AEterna Zentaris's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AEterna Zentaris Days Inventory Chart

AEterna Zentaris Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

644.16

99.06

190.43

346.15

244.97

AEterna Zentaris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															415.25	1,182.45	107.28	751.29	132.50

Competitive Comparison of AEterna Zentaris's Days Inventory

For the Biotechnology subindustry, AEterna Zentaris's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AEterna Zentaris's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AEterna Zentaris's Days Inventory distribution charts can be found below:

* The bar in red indicates where AEterna Zentaris's Days Inventory falls into.

AEterna Zentaris Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

AEterna Zentaris's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.311	+	0.089)	/	2 )	/	0.298	*	365
=	0.2					/	0.298	*	365
=	244.97

AEterna Zentaris's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.123	+	0.089)	/	2 )	/	0.073	*	365 / 4
=	0.106					/	0.073	*	365 / 4
=	132.50

AEterna Zentaris (TSX:AEZS) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

AEterna Zentaris's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.073	/	0.106
	=	0.69

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

AEterna Zentaris's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.106	/	0.162
	=	0.65

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

AEterna Zentaris Days Inventory Related Terms

Thank you for viewing the detailed overview of AEterna Zentaris's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

AEterna Zentaris (TSX:AEZS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (TSX:AEZS) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

AEZS:USA ET8:Germany

Address

222 Bay Street, Suite 3000, PO Box 53, c/o Norton Rose Fulbright Canada, LLP, Toronto, ON, CAN, M5K 1E7

Website

https://www.zentaris.com

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.